A new oral treatment for anemia in people with cancer
Treatments studied
Part of Blood & lymphatic, Cancer clinical trials.
This trial tests a new pill, AND017, for people with cancer who have low red blood cell counts (anemia) and are not getting chemotherapy. The goal is to see if the drug helps raise hemoglobin levels and reduce fatigue.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a cancer that is not leukemia or myeloma (your doctor can confirm).
- You are mobile enough to care for yourself and your doctor expects you to live at least 6 more months.
- Your hemoglobin is below 10 g/dL on two separate blood tests, at least a week apart.
- Your liver and kidneys are working well enough (based on blood test levels).
- You have not had chemotherapy, radiation, or bone-marrow-suppressing treatments in the past month.
- You do not have other causes of anemia (like iron deficiency, bleeding, or active infection).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an oral medication (AND017) to see if it can safely help raise hemoglobin levels in people with anemia caused by chemotherapy. If you have cancer (not leukemia) and are currently on chemo, this trial might help manage your anemia and improve your energy.
This trial tests a new oral medicine (AND017) for people on dialysis who have anemia (low red blood cells). It may help reduce the need for injections of standard anemia medicines.
This trial tests an experimental drug called AND017 for people with a certain type of myelodysplastic syndrome (MDS) that is low-risk and not linked to a chromosome 5 deletion. The goal is to see if AND017 can help improve low red blood cell counts (anemia) and reduce or avoid the need for blood transfusions.
This study tests a new medication (SAL-0951) for treating low red blood cell counts (anemia) caused by chemotherapy in people with certain types of cancer that are not curable. It may help improve energy and reduce the need for blood transfusions.
This trial tests an oral medication (AND017) for anemia caused by chronic kidney disease. It aims to improve red blood cell levels without needing dialysis or current anemia treatments.
This Phase 1 trial tests how safe APG-5918 is, how the body processes it, and looks for early signs it may help people with certain types of anemia. It may include healthy volunteers and people with anemia, but the study is very selective to protect participants.
Hear when a new Cancer-Related Anemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.